Shockwave Medical Announces Agreement to Acquire Neovasc
Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market
Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market
/PRNewswire/ -- MedRhythms announced today that the company's pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in...
/PRNewswire/ -- iSense and its co-founder Dr. Paul Andrew Rhodes have settled an investigation arising from a U.S. Defense Contract Audit Agency (DCAA) draft...
SALT LAKE CITY, UT / ACCESSWIRE / January 5, 2023 / ProLung, Inc. dba IONIQ Sciences, Inc. ("IONIQ" or the "Company") today announced it is presenting in person at Biotech Showcase, the investor conference
Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra-Glio', a blood test to help in the diagnosis of brain tumors